Article
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained…
medRxiv · 2021 · Mary S Pampusch
Key facts
| Title | CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection |
|---|---|
| First author | Mary S Pampusch |
| Journal | medRxiv |
| Published | Jul 26, 2021 |
| DOI | 10.1101/2021.07.26.453803 |
| Devices mentioned | K040782 |
| Product codes mentioned | JAK, JCC, MVU, NJT, PPM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1